17 hrs ago
Home Testing Devices Could Monitor EpilepsyDrug Levels, Reduce Clinical Visits
WASHINGTON D.C., December 9, 2013- Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures , or convulsions, during activities of daily living.
Data Shows ZonegranA (Zonisamide) is Well-Tolerated by Elderly Patients With Partial Epilepsy
Results from a pooled-analysis, published today in Acta Neurologica Scandinavica, show ZonegranA is a well-tolerated treatment for partial seizures with or without secondary generalisation in the elderly population , when used as a monotherapy or adjunctive therapy.
Augustine Movie Review
Charcot Island in Antarctica was discovered by Jean-Baptiste Charcot, who named it in honor of his father, Professor Jean-Martin Charcot, the founder of modern neurology.
Anticonvulsant effect of fisetin by modulation of endogenous biomarkers
Epilepsy is a group of disorders of the central nervous system bearing its pathological origin in paroxysysmal cerebral dysrhythmia, clinically consisting episodes of loss of consciousness.
Vivus: A New Twist On The Qnexa Story
VIVUS is a biotech company that has focused on anti-obesity treatment and its flagship drug Qnexa, as the objective of curbing obesity in patients.